Cargando…
Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients
Urothelial bladder carcinoma (UBC) is heterogeneous in its pathology and clinical behaviour. Evaluation of prognostic and predictive biomarkers is necessary, in order to produce personalised treatment options. The present study used immunohistochemistry to evaluate UBC sections containing tumour and...
Autores principales: | AFONSO, JULIETA, LONGATTO-FILHO, ADHEMAR, DA SILVA, VITOR MOREIRA, AMARO, TERESINA, SANTOS, LÚCIO L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156165/ https://www.ncbi.nlm.nih.gov/pubmed/25202348 http://dx.doi.org/10.3892/ol.2014.2392 |
Ejemplares similares
-
Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy
por: Afonso, Julieta, et al.
Publicado: (2023) -
Predictive Biomarkers of Bacillus Calmette-Guérin Immunotherapy Response in Bladder Cancer: Where Are We Now?
por: Lima, Luís, et al.
Publicado: (2012) -
An unusual case of asymptomatic non-urothelial bladder tumour
por: Ching, Daniel, et al.
Publicado: (2016) -
BCG Induced Necrosis of the Entire Bladder Urothelium
por: Krönig, Malte, et al.
Publicado: (2015) -
Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics
por: Costa, Céu, et al.
Publicado: (2015)